|
1
|
Bao YP, Yi Y, Peng LL, et al: Roles of
microRNA-206 in osteosarcoma pathogenesis and progression. Asian
Pac J Cancer Prev. 14:3751–3755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He ML, Wu Y, Zhao JM, Wang Z and Chen YB:
PIK3CA and AKT gene polymorphisms in susceptibility to osteosarcoma
in a Chinese population. Asian Pac J Cancer Prev. 14:5117–5122.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jia J, Tian Q, Liu Y, Shao ZW and Yang SH:
Interactive effect of bisphenol A (BPA) exposure with −22G/C
polymorphism in LOX gene on the risk of osteosarcoma. Asian Pac J
Cancer Prev. 14:3805–3808. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang W, Huang Y, Wang JP, Yu XY and Zhang
LY: The synergistic anticancer effect of artesunate combined with
allicin in osteosarcoma cell line in vitro and in
vivo. Asian Pac J Cancer Prev. 14:4615–4619. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun K and Lai EC: Adult-specific functions
of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miao J, Wu S, Peng Z, Tania M and Zhang C:
MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects.
Tumour Biol. 34:2093–2098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nugent M: MicroRNA function and
dysregulation in bone tumors: The evidence to date. Cancer Manag
Res. 6:15–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zou ZJ, Fan L, Wang L, et al: miR-26a and
miR-214 down-regulate expression of the PTEN gene in chronic
lymphocytic leukemia, but not PTEN mutation or promoter
methylation. Oncotarget. 6:1276–1285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao F, Xu G, Zhou Y, et al: MicroRNA-26b
inhibits hepatitis B virus transcription and replication by
targeting the host factor CHORDC1 protein. J Biol Chem.
289:35029–35041. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li H and Yang BB: Stress response of
glioblastoma cells mediated by miR-17-5p targeting PTEN and the
passenger strand miR-17-3p targeting MDM2. Oncotarget. 3:1653–1668.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han SB, Shin YJ, Hyon JY and Wee WR:
Cytotoxicity of voriconazole on cultured human corneal endothelial
cells. Antimicrob Agents Chemother. 55:4519–4523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong S, Cheng Y, Yang J, et al: MicroRNA
expression signature and the role of microRNA-21 in the early phase
of acute myocardial infarction. J Biol Chem. 284:29514–29525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q, Song XW, Zou J, et al: Attenuation
of microRNA-1 derepresses the cytoskeleton regulatory protein
twinfilin-1 to provoke cardiac hypertrophy. J Cell Sci.
123:2444–2452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang B, Liu XX, He JR, et al:
Pathologically decreased miR-26a antagonizes apoptosis and
facilitates carcinogenesis by targeting MTDH and EZH2 in breast
cancer. Carcinogenesis. 32:2–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alajez NM, Shi W, Hui AB, et al: Enhancer
of Zeste homolog 2 (EZH2) is overexpressed in recurrent
nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and
miR-98. Cell Death Dis. 1:e852010. View Article : Google Scholar : PubMed/NCBI
|
